These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 29084567)

  • 1. The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk.
    Femlak M; Gluba-Brzózka A; Ciałkowska-Rysz A; Rysz J
    Lipids Health Dis; 2017 Oct; 16(1):207. PubMed ID: 29084567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes.
    Passaro A; Vigna GB; Romani A; Sanz JM; Cavicchio C; Bonaccorsi G; Valacchi G; Cervellati C
    Oxid Med Cell Longev; 2018; 2018():1752940. PubMed ID: 30524650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the LDL subfraction phenotype on Lp-PLA2 distribution, LDL modification and HDL composition in type 2 diabetes.
    Sánchez-Quesada JL; Vinagre I; De Juan-Franco E; Sánchez-Hernández J; Bonet-Marques R; Blanco-Vaca F; Ordóñez-Llanos J; Pérez A
    Cardiovasc Diabetol; 2013 Aug; 12():112. PubMed ID: 23915379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral leishmaniasis is associated with marked changes in serum lipid profile.
    Liberopoulos EN; Apostolou F; Gazi IF; Kostara C; Bairaktari ET; Tselepis AD; Elisaf M
    Eur J Clin Invest; 2014 Aug; 44(8):719-27. PubMed ID: 24920396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes-induced Alterations in HDL Subfractions Distribution.
    Femlak M; Gluba-Brzozka A; Franczyk B; Rysz J
    Curr Pharm Des; 2020; 26(27):3341-3348. PubMed ID: 30827232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
    Navarro JF; Mora C; Muros M; García-Idoate G
    Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum advanced glycation end products are associated with impairment in HDL antioxidative capacity in diabetic nephropathy.
    Zhou H; Tan KC; Shiu SW; Wong Y
    Nephrol Dial Transplant; 2008 Mar; 23(3):927-33. PubMed ID: 18065800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetic dyslipidaemia and the atherosclerosis].
    Márk L; Dani G
    Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ; Yellon DM
    Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid modification in type 2 diabetes: the role of LDL and HDL.
    Vergès B
    Fundam Clin Pharmacol; 2009 Dec; 23(6):681-5. PubMed ID: 19650852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia.
    Brites FD; Verona J; Schreier LE; Fruchart JC; Castro GR; Wikinski RL
    Arch Med Res; 2004; 35(3):235-40. PubMed ID: 15163466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein metabolism in patients with type 1 diabetes under intensive insulin treatment.
    Feitosa AC; Feitosa-Filho GS; Freitas FR; Wajchenberg BL; Maranhão RC
    Lipids Health Dis; 2013 Feb; 12():15. PubMed ID: 23398881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum amyloid A and oxidative stress with paraoxonase 1 in sarcoidosis patients.
    Ivanišević J; Kotur-Stevuljević J; Stefanović A; Spasić S; Vučinić Mihailović V; Videnović Ivanov J; Jelić-Ivanović Z
    Eur J Clin Invest; 2016 May; 46(5):418-24. PubMed ID: 26919159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can paraoxonase 1 polymorphisms (L55 M and Q192 R) protect children with type 1 diabetes against lipid abnormalities?
    Fekih O; Triki S; Hellara I; Neffati F; Rejeb J; Ommezzine A; Chouchane S; Guediche MN; Bouslama A; Najjar MF
    J Clin Lipidol; 2014; 8(3):249-55. PubMed ID: 24793345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic basis of dyslipidemia in disease precipitation of coronary artery disease (CAD) associated type 2 diabetes mellitus (T2DM).
    Raj R; Bhatti JS; Badada SK; Ramteke PW
    Diabetes Metab Res Rev; 2015 Oct; 31(7):663-71. PubMed ID: 25470794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein hydrophobic core lipids are partially extruded to surface in smaller HDL: "Herniated" HDL, a common feature in diabetes.
    Amigó N; Mallol R; Heras M; Martínez-Hervás S; Blanco Vaca F; Escolà-Gil JC; Plana N; Yanes Ó; Masana L; Correig X
    Sci Rep; 2016 Jan; 6():19249. PubMed ID: 26778677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides.
    Mastorikou M; Mackness B; Liu Y; Mackness M
    Diabet Med; 2008 Sep; 25(9):1049-55. PubMed ID: 18937674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin but not bezafibrate decreases plasma lipoprotein-associated phospholipase A₂ mass in type 2 diabetes mellitus: relevance of high sensitive C-reactive protein, lipoprotein profile and low-density lipoprotein (LDL) electronegativity.
    Constantinides A; de Vries R; van Leeuwen JJ; Gautier T; van Pelt LJ; Tselepis AD; Lagrost L; Dullaart RP
    Eur J Intern Med; 2012 Oct; 23(7):633-8. PubMed ID: 22902096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.